title: Outcome for hospitalized patients with fever and neutropenia who are infected with the human immunodeficiency virus.
abstract: We conducted a retrospective cohort study to evaluate the occurrence of bacteremia and associated mortality among hospitalized patients who were seropositive for the human immunodeficiency virus (HIV) and who developed fever and neutropenia following antineoplastic chemotherapy or for other reasons. Review of medical records revealed 224 episodes in 142 patients. Of these episodes, 57% occurred following antineoplastic chemotherapy, and 43% occurred under other circumstances. Members of the chemotherapy group had significantly less-advanced HIV disease, a lower mean absolute-neutrophil-count nadir, and a shorter duration of hospitalization. There was no difference between the two groups in the frequency of bacteremia or mortality due to all causes when they were compared by multivariate analysis. Statistically significant univariate and multivariate predictors of bacteremia included sepsis syndrome and concurrent infection. Predictors of mortality included sepsis syndrome, concurrent infection, bacteremia, and antimicrobial therapy. This study suggests that the cause of neutropenia in HIV-seropositive patients is not a predictor of the outcome of fever and neutropenic episodes. Instead, clinical presentation and concomitant illnesses have a greater impact on outcome for a patient.
authors.affiliation: Department of Medicine, University of California, San Francisco 94143, USA.
authors.forename: J
authors.initials: J
authors.lastname: Hambleton
authors.forename: T
authors.initials: T
authors.lastname: Aragón
authors.forename: G
authors.initials: G
authors.lastname: Modin
authors.forename: D W
authors.initials: DW
authors.lastname: Northfelt
authors.forename: M A
authors.initials: MA
authors.lastname: Sande
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects; D016470:Bacteremia / Q000209:etiology* / Q000401:mortality; D015331:Cohort Studies; D005334:Fever / Q000209:etiology* / Q000401:mortality; D006679:HIV Seropositivity / Q000150:complications; D017052:Hospital Mortality; D006760:Hospitalization; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy; D009503:Neutropenia / Q000209:etiology* / Q000401:mortality; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D000970:Antineoplastic Agents